Extensive HLA class I allele promiscuity among viral CTL epitopes

European Journal of Immunology

Volumn 37, Issue 9, 2007, Pages 2419-2433

  Frahm, Nicole ^a   Yusim, Karina ^b   Suscovich, Todd J ^a   Adams, Sharon ^c   Sidney, John ^d   Hraber, Peter ^b   Hewitt, Hannah S ^a   Linde, Caitlyn H ^a   Kavanagh, Daniel G ^a   Woodberry, Tonia ^a   Henry, Leah M ^a   Faircloth, Kellie ^a   Listgarten, Jennifer ^e   Kadie, Carl ^e   Jojic, Nebosajsa ^e   Sango, Kaori ^a   Brown, Nancy V ^a   Pae, Eunice ^f   Zaman, M Tauheed ^g   Bihl, Florian ^a   Kahtri, Ashok ^a   John, Mina ^h   Mallal, Simon ^h   Marincola, Francesco M ^c   Walker, Bruce D ^a   Sette, Alessandro ^d   Heckerman, David ^e   Korber, Bette T ^b,i   Brander, Christian ^a   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^e MICROSOFT RESEARCH   (United States)

^f FENWAY INSTITUTE   (United States)

^g LEMUEL SHATTUCK HOSPITAL   (United States)

^h MURDOCH UNIVERSITY   (Australia)

ⁱ Santa Fe Institute   (United States)

Author keywords

Antigen; Bioinformatics; CD8 T cells; HIV; Immune responses

Indexed keywords

EPITOPE; HLA ANTIGEN CLASS 1; VIRUS ANTIGEN;

ALLELE; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE LOCUS; GENETIC CODE; HLA TYPING; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ALLELES; AMINO ACID SEQUENCE; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV; HUMANS; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES, CYTOTOXIC;

EID: 34548794906     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737365     Document Type: Article

References (58)

1. Guo, H. C., Jardetzky, T. S., Garrett, T. P., Lane, W. S., Strominger, J. L. and Wiley, D. C., Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature 1992. 360: 364-366.
2. Madden, D. R., The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 1995. 13: 587-622.
3. Matsumura, M., Fremont, D. H., Peterson, P. A. and Wilson, I. A., Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 1992. 257: 927-934.
4. Falk, K., Rotzschke, O., Stevanovic, S., Jung, G. and Rammensee, H. G., Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991. 351: 290-296.
5. Pamer, E. G., Harty, J. T. and Bevan, M. J., Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature 1991. 353: 852-855.
6. Bond, K. B., Sriwanthana, B., Hodge, T. W., De Groot, A. S., Mastro, T. D., Young, N. L., Promadej, N. et al., An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais. AIDS Res. Hum. Retroviruses 2001. 17: 703-717.
7. Brander, C., O'Connor, P., Suscovich, T., Jones, N. G., Lee, Y., Kedes, D., Ganem, D. et al., Definition of an optimal cytotoxic T lymphocyte epitope in the latently expressed Kaposi's sarcoma-associated herpesvirus kaposin protein. J. Infect. Dis. 2001. 184: 119-126.
8. Boisgerault, F., Khalil, L, Tieng, V., Connan, F., Tabary, T., Cohen, J. H., Choppin, J. et al., Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathy. Proc. Natl. Acad. Sci. USA 1996. 93: 3466-3470.
9. Kondo, E., Akatsuka, Y., Kuzushima, K., Tsujimura, K., Asakura, S., Tajima, K., Kagami, Y. et al., Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles. Blood 2004. 103: 630-638.
10. Sidney, J., del Guercio, M. F., Southwood, S., Engelhard, V. H., Appella, E., Rammensee, H. G., Falk, K. et al., Several HLA alleles share overlapping peptide specificities. J. Immunol. 1995. 154: 247-259.
11. Sette, A. and Sidney, J., Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 1999. 50: 201-212.
12. Lund, O., Nielsen, M., Kesmir, C., Petersen, A. G., Lundegaard, C., Worning, P., Sylvester-Hvid, C. et al., Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics 2004. 55: 797-810.
13. Frahm, N., Adams, S., Kiepiela, P., Linde, C. H., Hewitt, H. S., Lichterfeld, M., Sango, K. et al., HLA-B63 presents HLA-B57/ B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load. J. Virol. 2005. 79: 10218-10225.
14. Leslie, A., Price, D. A., Mkhize, P., Bishop, K., Rathod, A., Day, C., Crawford, H. et al., Differential selection pressure exerted on HIV by CTL targeting identical epitopes but restricted by distinct HLA alleles from the same HLA supertype. J. Immunol. 2006. 177: 4699-4708.
15. Panina-Bordignon, P., Tan, A., Termijtelen, A., Demotz, S., Corradin, G. and Lanzavecchia, A., Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol. 1989. 19: 2237-2242.
16. O'Sullivan, D., Arrhenius, T., Sidney, J., Del Guercio, M. F., Albertson, M., Wall, M., Oseroff, C. et al., On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs. J. Immunol. 1991. 147: 2663-2669.
17. Kaufmann, D. E., Bailey, P. M., Sidney, J., Wagner, B., Norris, P. J., Johnston, M. N., Cosimi, L. A. et al., Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J. Virol. 2004. 78: 4463-4477.
18. Kruger, S., Schroers, R., Rooney, C. M., Galin, B. and Chen, S. Y., Identification of a naturally processed HLA-DR-restricted T-helper epitope in Epstein-Barr virus nuclear antigen type 1. J. Immunother. 2003. 26: 212-221.
19. Doolan, D. L., Southwood, S., Chesnut, R., Appella, E., Gomez, E., Richards, A., Higashimoto, Y. I. et al., HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles. J. Immunol. 2000. 165: 1123-1137.
20. Ou, D., Mitchell, L. A. and Tingle, A. J., A new categorization of HLA DR alleles on a functional basis. Hum. Immunol. 1998. 59: 665-676.
21. Bian, H., Reidhaar-Olson, J. F. and Hammer, J., The use of bioinformatics for identifying class II-restricted T-cell epitopes. Methods 2003. 29: 299-309.
22. Masemola, A. M., Mashishi, T. N., Khoury, G., Bredell, H., Paximadis, M., Mathebula, T., Barkhan, D. et al., Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa. J. Immunol. 2004. 173: 4607-4617.
23. + T cell epitopes identified in US adolescent minorities. J. Acquir. Immune Defic. Syndr. 2003. 33: 426-438.
24. Threlkeld, S. C., Wentworth, P., Kalams, S., Johnson, P., Wilkens, B. M., Ruble, D. J., Sidney, J. et al., Degenerate and promiscuous recognition by cytotoxic T lymphocyte (CTL) of peptides presented by the MHC class I A3-like superfamily: Implications for vaccine development. J. Immunol. 1997. 159: 1648-1657.
25. Barber, L. D., Gillece-Castro, B., Percival, L., Li, X, Clayberger, C. and Parham, P., Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes. Curr. Biol. 1995. 5: 179-190.
26. Burrows, S. R., Elkington, R. A., Miles, J. J., Green, K. J., Walker, S., Haryana, S. M., Moss, D. J. et al., Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: biological validation of the proposed HLA A24 supertype. J. Immunol. 2003. 171: 1407-1412.
27. Ueno, T., Tomiyama, H. and Takiguchi, M., Single T cell receptor-mediated recognition of an identical HIV-derived peptide presented by multiple HLA class I molecules. J. Immunol. 2002. 169: 4961-4969.
28. Doolan, D. L., Hoffman, S. L., Southwood, S., Wentworth, P. A., Sidney, J., Chesnut, R. W., Keogh, E. et al., Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 1997. 7: 97-112.
29. Bertoni, R., Sidney, J., Fowler, P., Chesnut, R. W., Chisari, F. V. and Sette, A., Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J. Clin. Invest. 1997 100: 503-513.
30. Chang, K. M., Gruener, N. H., Southwood, S., Sidney, J., Pape, G. R., Chisari, F. V. and Sette, A., Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C. J. Immunol. 1999. 162: 1156-1164.
31. Brander, C. and Goulder, P. J. R., The identification of optimal HIV derived CTL epitopes in diverse populations using HIV clade specific consensus. In Korber, B. T., Brander, C., Haynes, B. F., Koup, R., Kuiken, C., Moore, J. P., Walker, B. D. and Watkins, D. I. (Eds.) HIV molecular immunology database. Theoretical Biology and Biophysics Group: Los Alamos National Laboratory, Los Alamos 2001, pp. 1-1-1-20.
32. Bihl, F. K., Loggi, E., Chisholm, J. V. 3rd, Hewitt, H. S., Henry, L. M., Linde, C., Suscovich, T. J. et al., Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "Recycle-Spot". J. Transl. Med. 2005. 3: 20.
33. Addo, M. M., Yu, X. G., Rathod, A., Cohen, D., Eldridge, R. L., Strick, D., Johnston, M. N. et al., Comprehensive epitope analysis of HIV-1-specific T cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 2003. 77: 2081-2092.
34. Frahm, N., Korber, B. T., Adams, C. M., Szinger, J. J., Draenert, R., Addo, M. M., Feeney, M. E. et al., Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J. Virol. 2004. 78: 2187-2200.
35. Frahm, N., Goulder, P. J. R. and Brander, C., Total assessment of HIV-specific CTL responses: Epitope clustering, processing preferences, and the impact of HIV sequence heterogeneity. In Korber, B. T., Brander, C., Haynes, B. F., Koup, R., Kuiken, C., Moore, J. P., Walker, B. D. and Watkins, D. I. (Eds.) HIV molecular immunology Compendium. Los Alamos National Laboratory, Theoretical Biology and Biophysics. LA-UR 03-5816, Los Alamos 2002, pp. 1-1-1-22.
36. Brander, C. and Walker, B. D., The HLA class I restricted CTL response in HIV infection: Identification of optimal epitopes. Los Alamas National Laboratory: Theoretical Biology and Biophysics, Los Alamos 1995
37. Bihl, F., Frahm, N., Di Giammarino, L., Sidney, J., John, M., Yusim, K., Woodberry, T. et al., Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses. J. Immunao. 2006. 176: 4094-4101.
38. Marsh, S. G. E., Parham, P. and Barber, L. D., The HLA FactsBook, 1st edn. Academic Press, London 2000
39. Rammensee, H., Bachmann, J., Emmerich, N. P., Bachor, O. A. and Stevanovic, S., SYFPEITHI: Database for MHC ligands and peptide motifs. Immunogenetics 1999. 50: 213-219.
40. Messaoudi, I., Guevara Patino, JA, Dyall, R., LeMaoult, J. and J., N.-Z., Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. Science 2002. 298: 1797-1780.
41. De Groot, A. S., Jesdale, B., Martin, W., Saint Aubin, C., Sbai, H., Bosma, A., Lieberman, J. et al., Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach. Vaccine 2003. 21: 4486-4504
42. Hunziker, I. P., Cerny, A. and Pichler, W. J., Who is right? Or, how to judge the disagreement about HLA restriction of Nef peptides. AIDS Res. Hum. Retroviruses 1998. 14: 921-924.
43. Parker, K. C., Bednarek, M. A., Hull, L. K., Utz, U., Cunningham, B. Zweerink, H. J., Biddison, W. E. and Coligan, J. E., Sequence motis important for peptide binding to the human MHC class I molecule, HLA-A2. J. Immunol. 1992. 149: 3580-3587
44. Ruppert, J., Sidney, J., Celis, E., Kubo, R. T., Grey, H. M. and Sette, A., Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 1993. 74: 929-937
45. Sidney, J., Grey, H. M., Kubo, R. T. and Sette, A., Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol. Today 1996. 17: 216-216.
46. + T-cell epitopes within hepatitis C virus NS3 and NS4 proteins. J. Virol 2005. 79: 12425-12433.
47. Mazzarino, P., Pietra, G., Vacca, P., Falco, M., Colau, D., Coulie, P., Moretta, L. and Mingari, M. C., Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion. Eur. J. Immunol. 2005. 35: 3240-3247.
48. Romagnani, C., Pietra, G., Falco, M., Mazzarino, P., Moretta, L. and Mingari, M. C., HLA-E-restricted recognition of human cytormegalovirus by a subset of cytolytic T lymphocytes. Hum. Immunol. 2004. 65: 437-445.
49. + T cells. J. Exp. Med. 2002. 196: 1473-1481.
50. + T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J. Immunol. 2004. 173: 5852-5862.
51. Moore, C. B., John, M., James, I. R., Christiansen, F. T., Witt, C. S. and Mallal, S. A., Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002. 296: 1439-1443.
52. Leslie, A., Kavanagh, D., Honeyborne, L, Pfafferott, K., Edwards, C., Pillay, T., Hilton, L. et al., Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA. J. Exp. Med. 2005. 201: 891-902.
53. Bhattacharya, T., Daniels, M., Heckerman, D., Foley, B., Frahm, N., Kadie, C., Carlson, J. et al., Founder effects in population based assessment of HIV polymorphisms and HLA allele associations. Science 2007. 315: 1583-1586.
54. Carrington, M., Neslon, G., Martin, M. P., Kissner, T., Vlahov, D., Goedert, J. J., Kaslow, R. et al., HLA and HIV-1: Heterozygote advantage and B*35-Cw04 disadvantage. Science 1999. 283: 1748-1752.
55. Goulder, P. J., Addo, M. M., Altfeld, M. A., Rosenberg, E. S., Tang, Y., Govender, U., Mngqundaniso, N. et al., Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by ELISPOT and intracellular cytokine staining assays. J. Virol. 2001. 75: 1339-1347.
56. Kiepiela, P., Leslie, A. J., Honeyborne, L, Ramduth, D., Thobakgale, C., Chetty, S., Rathnavalu, P. et al., Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004. 432: 769-775.
57. Benjamini, Y. and Hochberg, Y., Controlling the false discovery rate: A practical and powerful apporach to multiple testing. J. P, Star. Soc. B 1995. 57: 289-300.
58. + T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef. Blood 2006. 107: 1963-1969.